HomeNDC LookupRxCUI directory › RxCUI 899549

Dexmethylphenidate hydrochloride 10 MG Oral Tablet [Focalin] — RxCUI 899549

RxNorm drug concept · Semantic branded drug
RxCUI 899549 Semantic branded drug · SBD ● Current RxNorm concept 6 FDA products 4 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI899549
Official nameDexmethylphenidate hydrochloride 10 MG Oral Tablet [Focalin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asFocalin 10 MG Oral Tablet
FDA products mapped6
Package NDCs mapped4
Reported Medicaid activity (SDUD)5,493 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dexmethylphenidate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Dexmethylphenidate is essentially the more active half of methylphenidate — think of it as a more refined version. Regular methylphenidate (like Ritalin) is a mix of two mirror-ima...
  • What exactly is dexmethylphenidate and how is it different from regular methylphenidate (Ritalin)?
  • Either way is fine — dexmethylphenidate can be taken with or without food. If you're taking the extended-release capsule and you can't swallow it whole, you can open it and sprinkl...
  • Should I take this with food or on an empty stomach?
📖 Read our full Dexmethylphenidate guide →

🕸️ Concept Web — How Dexmethylphenidate hydrochloride 10 MG Oral Tabl... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dexmethylphenidate hydrochloride 10 MG Oral Tablet [Focalin] RxCUI 899549

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Dexmethylphenidate 352372
    • Dexmethylphenidate hydrochloride 353105
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Focalin 352654
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dexmethylphenidate Oral Tablet 378713
    • Dexmethylphenidate hydrochloride Oral Tablet 2648102
    • Dexmethylphenidate Oral Product 1157802
    • Dexmethylphenidate Pill 1158298
    • Dexmethylphenidate hydrochloride Oral Product 2662739
    • Dexmethylphenidate hydrochloride Pill 2659215
    • Dexmethylphenidate Oral Tablet [Focalin] 369443
    • Dexmethylphenidate hydrochloride Oral Tablet [Focalin] 2654625
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dexmethylphenidate hydrochloride 10 MG Oral Tablet SCD · 899548
  • Dexmethylphenidate hydrochloride 10 MG SCDC · 899438
  • Dexmethylphenidate Oral Tablet SCDF · 378713
  • Dexmethylphenidate hydrochloride Oral Tablet SCDFP · 2648102
  • Dexmethylphenidate Oral Product SCDG · 1157802
  • Dexmethylphenidate Pill SCDG · 1158298
  • Dexmethylphenidate hydrochloride Oral Product SCDGP · 2662739
  • Dexmethylphenidate hydrochloride Pill SCDGP · 2659215

Brand-Name Concepts

  • Dexmethylphenidate hydrochloride 10 MG [Focalin] SBDC · 899440
  • Dexmethylphenidate Oral Tablet [Focalin] SBDF · 369443
  • Dexmethylphenidate hydrochloride Oral Tablet [Focalin] SBDFP · 2654625
  • Focalin Oral Product SBDG · 1171880
  • Focalin Pill SBDG · 1171881
  • Focalin BN · 352654

📦 FDA Products & Package NDCs

6 products · 4 package NDCs
4 package NDCs map to RxCUI 899549 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00078-0381-05 100 TABLET in 1 BOTTLE (0078-0381-05) Focalin Novartis Pharmaceuticals Corporation 2001-11-30
66758-0250-01 100 TABLET in 1 BOTTLE (66758-250-01) Focalin Sandoz Inc 2024-08-16
66758-0251-01 100 TABLET in 1 BOTTLE (66758-251-01) Focalin Sandoz Inc 2025-03-01
66758-0252-01 100 TABLET in 1 BOTTLE (66758-252-01) Focalin Sandoz Inc 2024-07-12
Observed labelers: Sandoz Inc (3) · Novartis Pharmaceuticals Corporation (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.